Mphasis has been recommended as a buy at ₹2,465, with the call anchored to the stock trading above its 200-day moving average. The same recommendation has now been carried across two consecutive sessions, indicating the setup remains intact. No new price levels or fundamental catalysts have emerged beyond the original technical trigger.
No articles in the last 24 hours. Expand to 1 week
